XML 84 R51.htm IDEA: XBRL DOCUMENT v2.4.0.6
Financial Instruments And Risk Management (Financial Assets And Liabilities Carried At Fair Value) (Details) (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2011
Dec. 31, 2010
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Trading securities $ 6,760 $ 3,693
Available-for-sale fixed income investments 23,754 25,010
Available-for-sale equity securities 23,926 25,392
Total Assets 524,261 [1] 513,037 [1]
Total Liabilities 529,493 [1] 505,441 [1]
Level 1 [Member]
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Trading securities 6,760 3,693
Available-for-sale fixed income investments     
Total Assets 6,932 [1] 4,075 [1]
Total Liabilities    [1]  
Level 2 [Member]
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Trading securities     
Available-for-sale fixed income investments 23,754 25,010
Total Assets 517,329 [1] 508,962 [1]
Total Liabilities 529,493 [1] 505,441 [1]
Equity Securities [Member]
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Trading securities 6,760 3,693
Available-for-sale equity securities 172 382
Equity Securities [Member] | Level 1 [Member]
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Trading securities 6,760 3,693
Available-for-sale equity securities 172 382
Equity Securities [Member] | Level 2 [Member]
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Trading securities     
Available-for-sale equity securities     
Biosciences Industry [Member]
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale equity securities 172 382
Biosciences Industry [Member] | Level 1 [Member]
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale equity securities 172 382
Biosciences Industry [Member] | Level 2 [Member]
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale equity securities     
U.S. Treasuries [Member]
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale fixed income investments 1,519 12,387
U.S. Treasuries [Member] | Level 2 [Member]
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale fixed income investments 1,519 12,387
Corporate Bonds [Member]
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale fixed income investments 7,192 8,116
Corporate Bonds [Member] | Level 1 [Member]
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale fixed income investments     
Corporate Bonds [Member] | Level 2 [Member]
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale fixed income investments 7,192 8,116
Agency Mortgage-Backed Securities [Member]
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale fixed income investments 12,346 1,934
Agency Mortgage-Backed Securities [Member] | Level 1 [Member]
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale fixed income investments     
Agency Mortgage-Backed Securities [Member] | Level 2 [Member]
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale fixed income investments 12,346 1,934
Other [Member]
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale fixed income investments 2,697 2,573
Other [Member] | Level 1 [Member]
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale fixed income investments     
Other [Member] | Level 2 [Member]
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Available-for-sale fixed income investments 2,697 2,573
Foreign Exchange Derivative Assets [Member]
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative assets 3,802 11,552
Foreign Exchange Derivative Assets [Member] | Level 1 [Member]
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative assets     
Foreign Exchange Derivative Assets [Member] | Level 2 [Member]
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative assets 3,802 11,552
Interest Rate Swaps [Member]
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative assets 29,773  
Interest Rate Swaps [Member] | Level 2 [Member]
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative assets 29,773  
Purchased Cash Convertible Note Hedge [Member]
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative assets 460,000 472,400
Purchased Cash Convertible Note Hedge [Member] | Level 1 [Member]
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative assets     
Purchased Cash Convertible Note Hedge [Member] | Level 2 [Member]
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative assets 460,000 472,400
Foreign Exchange Derivative Liabilities [Member]
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative liabilities 68,835 7,375
Foreign Exchange Derivative Liabilities [Member] | Level 1 [Member]
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative liabilities     
Foreign Exchange Derivative Liabilities [Member] | Level 2 [Member]
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative liabilities 68,835 7,375
Interest Rate Swap Derivative Liabilities [Member]
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative liabilities 658 25,666
Interest Rate Swap Derivative Liabilities [Member] | Level 1 [Member]
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative liabilities     
Interest Rate Swap Derivative Liabilities [Member] | Level 2 [Member]
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative liabilities 658 25,666
Cash Conversion Feature Of Cash Convertible Notes [Member]
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative liabilities 460,000 472,400
Cash Conversion Feature Of Cash Convertible Notes [Member] | Level 1 [Member]
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative liabilities     
Cash Conversion Feature Of Cash Convertible Notes [Member] | Level 2 [Member]
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Derivative liabilities $ 460,000 $ 472,400
[1] The Company chose not to elect the fair value option for its financial assets and liabilities that had not been previously carried at fair value. Therefore, material financial assets and liabilities not carried at fair value, such as short-term and long-term debt obligations and trade accounts receivable and payable, are still reported at their carrying values.